South Africa Hereditary Angioedema Market (2025-2031) | Growth, Companies, Segmentation, Outlook, Size & Revenue, Trends, Forecast, Analysis, Competitive Landscape, Industry, Value, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Africa Country Macro Economic Indicators

3.2 South Africa Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 South Africa Hereditary Angioedema Market - Industry Life Cycle

3.4 South Africa Hereditary Angioedema Market - Porter's Five Forces

3.5 South Africa Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 South Africa Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 South Africa Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis of hereditary angioedema in South Africa

4.2.2 Advancements in treatment options and therapies for hereditary angioedema

4.2.3 Growing healthcare infrastructure and access to specialized care for rare diseases in South Africa

4.3 Market Restraints

4.3.1 High cost of treatment and limited access to expensive medications for hereditary angioedema

4.3.2 Lack of healthcare professionals with expertise in managing hereditary angioedema cases in South Africa

6.1 South Africa Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 South Africa Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 South Africa Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 South Africa Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 South Africa Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 South Africa Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 South Africa Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 South Africa Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 South Africa Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 South Africa Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 South Africa Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 South Africa Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 South Africa Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 South Africa Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7.1 South Africa Hereditary Angioedema Market Export to Major Countries

7.2 South Africa Hereditary Angioedema Market Imports from Major Countries

8.1 Average time to diagnosis of hereditary angioedema patients in South Africa

8.2 Number of specialized treatment centers for hereditary angioedema in South Africa

8.3 Patient adherence rates to prescribed treatment plans for hereditary angioedema

9.1 South Africa Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 South Africa Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 South Africa Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 South Africa Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 South Africa Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters